Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Titel:
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Auteur:
Badoux, Xavier C. Keating, Michael J. Wang, Xuemei O'Brien, Susan M. Ferrajoli, Alessandra Faderl, Stefan Burger, Jan Koller, Charles Lerner, Susan Kantarjian, Hagop Wierda, William G.